These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1751 related items for PubMed ID: 27415829

  • 21. Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with carboplatin used for ovarian, tubal, and primary peritoneal cancer.
    Mikkelsen MS, Christiansen T, Petersen LK, Blaakaer J, Iversen LH.
    J Surg Oncol; 2019 Sep; 120(3):550-557. PubMed ID: 31267569
    [Abstract] [Full Text] [Related]

  • 22. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC, Medina-Fernández FJ, Arjona-Sánchez Á, Casado-Adam Á, Sánchez-Hidalgo JM, Rubio MJ, Ortega-Salas R, Muñoz-Villanueva MC, Rufián-Peña S, Briceño FJ.
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [Abstract] [Full Text] [Related]

  • 23. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y, Li XB, Lin YL, Ma R, Ji ZH, Zhang YB, An SL, Liu G, Yang XJ, Li Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar 25; 24(3):230-239. PubMed ID: 34645167
    [Abstract] [Full Text] [Related]

  • 24. Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chambers LM, Yao M, Morton M, Gruner M, Chichura A, Horowitz M, Costales AB, Rose PG, Michener CM, Debernardo R.
    Gynecol Oncol; 2021 May 25; 161(2):389-395. PubMed ID: 33551202
    [Abstract] [Full Text] [Related]

  • 25. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M, Vaira M, Marsanic P, Mellano A, Borsano A, Cinquegrana A, Sottile A, De Simone M.
    Minerva Chir; 2014 Feb 25; 69(1):27-35. PubMed ID: 24675244
    [Abstract] [Full Text] [Related]

  • 26. Combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as a treatment for recurrent epithelial ovarian cancer-National Cancer Institute experience.
    Fahim MI, Nassar OA, Mansour OM, Ali AM, Mahmoud AM, Allam RM, Kamal A.
    J Egypt Natl Canc Inst; 2018 Dec 25; 30(4):139-141. PubMed ID: 30470604
    [Abstract] [Full Text] [Related]

  • 27. Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
    Zambrano-Vera K, Sardi A, Lopez-Ramirez F, Sittig M, Munoz-Zuluaga C, Nieroda C, Gushchin V, Diaz-Montes T.
    Ann Surg Oncol; 2021 Aug 25; 28(8):4655-4666. PubMed ID: 33393042
    [Abstract] [Full Text] [Related]

  • 28. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
    Auer RC, Sivajohanathan D, Biagi J, Conner J, Kennedy E, May T.
    Eur J Cancer; 2020 Mar 25; 127():76-95. PubMed ID: 31986452
    [Abstract] [Full Text] [Related]

  • 29. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
    Rihuete Caro C, Manzanedo I, Pereira F, Carrion-Alvarez L, Serrano Á, Pérez-Viejo E.
    Eur J Surg Oncol; 2018 Nov 25; 44(11):1805-1810. PubMed ID: 30087071
    [Abstract] [Full Text] [Related]

  • 30. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience.
    Königsrainer I, Horvath P, Struller F, Grischke EM, Wallwiener D, Königsrainer A, Beckert S.
    Langenbecks Arch Surg; 2014 Jun 25; 399(5):589-94. PubMed ID: 24817542
    [Abstract] [Full Text] [Related]

  • 31. Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
    Durán-Martínez M, Gómez-Dueñas G, Rodriguez-Ortíz L, Sanchez-Hidalgo JM, Gordón-Suárez A, Casado-Adam Á, Rufián-Peña S, Valenzuela-Molina F, Rufián-Andujar B, Vázquez-Borrego MC, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez Á.
    Surg Endosc; 2024 Jan 25; 38(1):66-74. PubMed ID: 37903884
    [Abstract] [Full Text] [Related]

  • 32. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma.
    Lopez-Ramirez F, Sardi A, Studeman K, King MC, Falla-Zuniga LF, Nikiforchin A, Baron E, Nieroda C, Gushchin V, Diaz-Montes T.
    Eur J Surg Oncol; 2023 Aug 25; 49(8):1495-1503. PubMed ID: 37068984
    [Abstract] [Full Text] [Related]

  • 33. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M, Robella M, Mellano A, Sottile A, De Simone M.
    Int J Hyperthermia; 2014 Dec 25; 30(8):565-9. PubMed ID: 25430988
    [Abstract] [Full Text] [Related]

  • 34. Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer.
    Magge D, Ramalingam L, Shuai Y, Edwards RP, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA.
    J Surg Oncol; 2017 Sep 25; 116(3):320-328. PubMed ID: 28628712
    [Abstract] [Full Text] [Related]

  • 35. Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy.
    Lee JY, Lee YJ, Son JH, Kim S, Choi MC, Suh DH, Song JY, Hong DG, Kim MK, Kim JH, Chang SJ.
    JAMA Surg; 2023 Nov 01; 158(11):1133-1140. PubMed ID: 37672264
    [Abstract] [Full Text] [Related]

  • 36. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma.
    Tabrizian P, Franssen B, Jibara G, Sweeney R, Sarpel U, Schwartz M, Labow D.
    J Surg Oncol; 2014 Dec 01; 110(7):786-90. PubMed ID: 25091997
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.
    Wong JF, Tan GH, Wang W, Soo KC, Teo MC.
    World J Surg; 2015 Jun 01; 39(6):1578-83. PubMed ID: 25651962
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.
    Mercier F, Bakrin N, Bartlett DL, Goere D, Quenet F, Dumont F, Heyd B, Abboud K, Marolho C, Villeneuve L, Glehen O, PSOGI Working Group, BIG-RENAPE Working Group.
    Ann Surg Oncol; 2018 Jun 01; 25(6):1668-1675. PubMed ID: 29637438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 88.